{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:29:45Z","timestamp":1793424585460,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with primary intestinal follicular lymphoma are often followed-up without a specific treatment, and this approach is called the \u201cwatch-and-wait approach.\u201d However, the long-term outcomes of this patient group have not been sufficiently investigated. We enrolled patients with primary intestinal follicular lymphoma who were diagnosed before 2016 and managed with the watch-and-wait approach in 20 institutions. We retrospectively investigated the overall, disease-specific, and event-free survival rates as well as the rate of spontaneous regression. Among the 248 patients with follicular lymphoma with gastrointestinal involvement, 124 had localized disease (stage I or II<jats:sub>1<\/jats:sub>). We analyzed the data of 73 patients who were managed using the watch-and-wait approach. During the mean follow-up period of 8.3\u00a0years, the follicular lymphoma had spontaneously resolved in 16.4% of the patients. The 5-year and 10-year overall survival rates were 92.9% and 87.1%, respectively. With disease progression (n\u2009=\u20097), initiation of therapy (n\u2009=\u20097), and histologic transformation to aggressive lymphoma (n\u2009=\u20090) defined as events, the 5-year and 10-year event-free survival rates were 91.1% and 86.9%, respectively. No patient died of progressive lymphoma. Thus, both 5-year and 10-year disease-specific survival rates were 100%. In conclusion, an indolent long-term clinical course was confirmed in the patients with primary intestinal follicular lymphoma. The watch-and-wait strategy is a reasonable approach for the initial management of these patients.<\/jats:p>","DOI":"10.1038\/s41598-023-32736-9","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T10:02:57Z","timestamp":1681207377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy"],"prefix":"10.1038","volume":"13","author":[{"given":"Masaya","family":"Iwamuro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ennishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Matsueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruya","family":"Nagahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Mannami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Toyokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Tsugeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiyuu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"32736_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.hoc.2020.02.001","volume":"34","author":"JR Cerhan","year":"2020","unstructured":"Cerhan, J. R. Epidemiology of follicular lymphoma. Hematol. Oncol. Clin. N. Am. 34, 631\u2013646 (2020).","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"32736_CR2","first-page":"97","volume":"36","author":"KE Cahill","year":"2022","unstructured":"Cahill, K. E. & Smith, S. M. Follicular lymphoma: A focus on current and emerging therapies. Oncology (Williston Park) 36, 97\u2013106 (2022).","journal-title":"Oncology (Williston Park)"},{"key":"32736_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1470-2045(14)70027-0","volume":"15","author":"KM Ardeshna","year":"2014","unstructured":"Ardeshna, K. M. et al. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncol. 15, 424\u2013435 (2014).","journal-title":"Lancet Oncol."},{"key":"32736_CR4","doi-asserted-by":"crossref","unstructured":"Dreyling, M., et al. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. Suppl 3: iii76\u201382 (2014).","DOI":"10.1093\/annonc\/mdu200"},{"key":"32736_CR5","unstructured":"Harris, N.L., et al. Follicular lymphoma. In: Swerdlow, S.H., et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC, 220\u2013226 (2008)."},{"key":"32736_CR6","unstructured":"Yoshino, T., Chott, A. Duodenal-type follicular lymphoma. In: WHO Classification of Tumours Editorial Board, editors. WHO Classification of Tumours of Digestive System Tumours. Lyon: IARC, 383\u2013385 (2019)."},{"key":"32736_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0032-1325979","volume":"45","author":"M Nakamura","year":"2013","unstructured":"Nakamura, M. et al. Endoscopic diagnosis of follicular lymphoma with small-bowel involvement using video capsule endoscopy and double-balloon endoscopy: A case series. Endoscopy 45, 67\u201370 (2013).","journal-title":"Endoscopy"},{"key":"32736_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3892\/ol.2015.3251","volume":"10","author":"M Iwamuro","year":"2015","unstructured":"Iwamuro, M. et al. A multicenter survey of enteroscopy for the diagnosis of intestinal follicular lymphoma. Oncol. Lett. 10, 131\u2013136 (2015).","journal-title":"Oncol. Lett."},{"key":"32736_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1055\/s-0028-1119467","volume":"41","author":"N Higuchi","year":"2009","unstructured":"Higuchi, N. et al. Impact of double-balloon endoscopy on the diagnosis of jejunoileal involvement in primary intestinal follicular lymphomas: A case series. Endoscopy 41, 175\u2013178 (2009).","journal-title":"Endoscopy"},{"key":"32736_CR10","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3748\/wjg.v22.i4.1674","volume":"22","author":"M Iwamuro","year":"2016","unstructured":"Iwamuro, M., Kondo, E., Takata, K., Yoshino, T. & Okada, H. Diagnosis of follicular lymphoma of the gastrointestinal tract: A better initial diagnostic workup. World J. Gastroenterol. 22, 1674\u20131683 (2016).","journal-title":"World J. Gastroenterol."},{"key":"32736_CR11","doi-asserted-by":"publisher","first-page":"6427","DOI":"10.3748\/wjg.v18.i44.6427","volume":"18","author":"M Iwamuro","year":"2012","unstructured":"Iwamuro, M. et al. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement. World J. Gastroenterol. 18, 6427\u20136436 (2012).","journal-title":"World J. Gastroenterol."},{"key":"32736_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.clinbiochem.2013.11.026","volume":"47","author":"M Iwamuro","year":"2014","unstructured":"Iwamuro, M. et al. Elevated soluble IL-2 receptor levels correlate with tumor bulk of follicular lymphomas with intestinal involvement. Clin. Biochem. 47, 191\u2013195 (2014).","journal-title":"Clin. Biochem."},{"key":"32736_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.anndiagpath.2013.12.006","volume":"18","author":"M Iwamuro","year":"2014","unstructured":"Iwamuro, M. et al. Diagnostic accuracy of endoscopic biopsies for the diagnosis of gastrointestinal follicular lymphoma: a clinicopathologic study of 48 patients. Ann. Diagn. Pathol. 18, 99\u2013103 (2014).","journal-title":"Ann. Diagn. Pathol."},{"key":"32736_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2169\/internalmedicine.55.5393","volume":"55","author":"M Iwamuro","year":"2016","unstructured":"Iwamuro, M. et al. Colorectal manifestation of follicular lymphoma. Intern. Med. 55, 1\u20138 (2016).","journal-title":"Intern. Med."},{"key":"32736_CR15","first-page":"391","volume":"71","author":"M Iwamuro","year":"2017","unstructured":"Iwamuro, M. et al. The usefulness of colonoscopy for the detection of ileal involvement in intestinal follicular lymphoma patients. Acta Med. Okayama 71, 391\u2013398 (2017).","journal-title":"Acta Med. Okayama"},{"key":"32736_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","volume":"5","author":"A Rohatiner","year":"1994","unstructured":"Rohatiner, A. et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann. Oncol. 5, 397\u2013400 (1994).","journal-title":"Ann. Oncol."},{"key":"32736_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.annonc.2020.11.008","volume":"32","author":"M Dreyling","year":"2021","unstructured":"Dreyling, M. et al. Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 32, 298\u2013308 (2021).","journal-title":"Ann. Oncol."},{"key":"32736_CR18","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1200\/JCO.2010.32.9193","volume":"29","author":"AI Schmatz","year":"2011","unstructured":"Schmatz, A. I. et al. Primary follicular lymphoma of the duodenum is a distinct mucosal\/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J. Clin. Oncol. 29, 1445\u20131451 (2011).","journal-title":"J. Clin. Oncol."},{"key":"32736_CR19","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/j.1349-7006.2011.01980.x","volume":"102","author":"K Takata","year":"2011","unstructured":"Takata, K. et al. Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: a multicenter, retrospective analysis in Japan. Cancer Sci. 102, 1532\u20131536 (2011).","journal-title":"Cancer Sci."},{"key":"32736_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5009\/gnl210300","volume":"16","author":"T Matysiak-Budnik","year":"2022","unstructured":"Matysiak-Budnik, T. et al. Primary gastrointestinal follicular lymphomas: a prospective study of 31 patients with long-term follow-up registered in the French Gastrointestinal Lymphoma Study Group (GELD) of the French Federation of Digestive Oncology (FFCD). Gut Liver 16, 207\u2013215 (2022).","journal-title":"Gut Liver"},{"key":"32736_CR21","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/jgh.14100","volume":"33","author":"A Tari","year":"2018","unstructured":"Tari, A. et al. Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. J. Gastroenterol. Hepatol. 33, 1461\u20131468 (2018).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"32736_CR22","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/00000478-200005000-00007","volume":"24","author":"T Yoshino","year":"2000","unstructured":"Yoshino, T. et al. Increased incidence of follicular lymphoma in the duodenum. Am. J. Surg. Pathol. 24, 688\u2013693 (2000).","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32736-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32736-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T10:13:05Z","timestamp":1681207985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32736-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32736"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32736-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"6 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5858"}}